Abstract:OBJECTIVE:Portal vein metastasis of hepatocellular carcinoma (HCC) results in a poor prognosis and seriously affects the survival rate of patients. The mechanism underlying the formation of portal vein tumor thrombus (PVTT) is complex and is not yet fully understood. This study was conducted to investigate the impact of portal vein blood on the proliferation, metastasis, invasion and apoptosis of PVTT cells and to explore its possible mechanisms, which was expected to lay a foundation for ascertaining the mechanism underlying the portal vein metastasis of HCC. METHODS:Peripheral blood and portal vein blood were collected from patients with HCC, and the sera from these two sources were used to culture the PVTT-originated HCC cell line CSQT-2. The cells were collected after 24 h, and flow cytometry was performed to detect cell proliferation, cell cycle stages and apoptosis. Transwell migration and invasion assays were applied to detect the metastasis and invasion of the cells in each group. The changes in the expression of MMP-2 and MMP-9 in cells were detected via Western blotting. The contents of IL-12, IFN-γ, IL-1β, IL-2 and TNF-α in the two groups of sera were quantified using corresponding kits. RESULTS:Compared with the group of cells cultured with peripheral serum, the cells cultured with portal vein serum showed significantly lower apoptosis (P<0.01), significantly enhanced cell metastasis and invasion (P<0.01), whereas cell proliferation and the stages of the cell cycle did not differ significantly (P>0.05). A significantly increased expression level of MMP-2 has been observed in tumor cells treated portal vein serum. In addition, compared with peripheral serum, the content of IL-12 was significantly decreased in portal vein serum (P<0.05), while the contents of IFN-γ, IL-1β, IL-2, and TNF-α did not differ significantly (P>0.05). CONCLUSIONS:Portal vein serum from HCC patients could inhibit the apoptosis of PVTT-originated HCC cells and promote cell metastasis and invasion. This effect may be related to the lower level of IL-12 in portal vein serum.

Expression and significance of scinderin in hepatocellular carcinoma with portal vein tumor thrombus

Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma

Clinicopathological Significance of Survivin Mrna Expression in HCC

Expression and Significance of SCIN in Breast Cancer Tissue

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer.

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

Scinderin is a Novel Transcriptional Target of BRMS1 Involved in Regulation of Hepatocellular Carcinoma Cell Apoptosis.

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

[Expression of Survivin, P27 and PTEN in Hepatocellular Carcinoma and Their Clinical Significances].

Relationship of intratumoral regulatory T cells infiltration and portal vein tumor thrombus formation with prognosis in hepatocellular carcinoma

Chemerin in Hepatocelluar Carcinoma: Expressions and Prognostic Values

Foxp3+ Regulatoryt Cells and the Formation of Portal Vein Tumour Thrombus in Patients with Hepatocellular Carcinoma

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Expression of Scavenger receptor class A, member 5 protein in hepatocellular carcinoma and the relationship with promoter methylation

Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway.

Expression of Survivin and Nm23-H1 and Their Clinical Significance in Hepatocellular Carcinoma

Expression of the Chemokine Receptor CXCR4 in Human Hepatocellular Carcinoma and Its Role in Portal Vein Tumor Thrombus

Proteomics Analysis of Distinct Portal Vein Tumor Thrombi in Hepatocellular Carcinoma Patients

Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma.

Experimental Study on Enhancement of the Metastatic Potential of Portal Vein Tumor Thrombus-Originated Hepatocellular Carcinoma Cells Using Portal Vein Serum.